Reported by Dow Jones last week: Egyptian authorities seized a large amount of suspected counterfeit drugs from a warehouse in Egypt and have one of the key individuals responsible in custody.
The seizure of counterfeit drugs used to treat conditions such as diabetes and cancer were part of Egypt’s crackdown on the distribution of spurious medicines, which is on the increase in the region. The head of Egypt's anti-fraud General Mustafa Amr stated to Dow Jones reporters that the counterfeit drugs found in the raid had originated in China and arrived in Egypt after passing through Syria. The individual arrested was a Jordanian residing in Egypt.
A Pfizer spokesman stated that they had been informed of the raid and added that 21,000 pills of suspected fake Dostinex were seized in the raids. The brand drug Dostinex is manufactured by Pfizer for the treatment of hyperprolactinaemia, which is the presence of abnormally high levels of the hormone prolactin in the blood.
The seizure of counterfeit drugs used to treat conditions such as diabetes and cancer were part of Egypt’s crackdown on the distribution of spurious medicines, which is on the increase in the region. The head of Egypt's anti-fraud General Mustafa Amr stated to Dow Jones reporters that the counterfeit drugs found in the raid had originated in China and arrived in Egypt after passing through Syria. The individual arrested was a Jordanian residing in Egypt.
A Pfizer spokesman stated that they had been informed of the raid and added that 21,000 pills of suspected fake Dostinex were seized in the raids. The brand drug Dostinex is manufactured by Pfizer for the treatment of hyperprolactinaemia, which is the presence of abnormally high levels of the hormone prolactin in the blood.
Note: According to the Organisation for Economic Co-operation and Development (OECD), 7% of all counterfeit pharmaceuticals distributed globally are thought to originate in Egypt.
Posts
No comments:
Post a Comment